Lookup NU author(s): Dr Aikaterini Gatsiou,
Professor Konstantinos Stellos
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Medicine is at the crossroads of expanding disciplines. Prompt adaptation of medicine to each rapidly advancing research field, bridging bench to bedside, is a key step toward health improvement. Cardiovascular disease still ranks first among the mortality causes in the Western world, indicating a poor adaptation rate of cardiovascular medicine, albeit the gigantic scientific breakthroughs of this century. This urges the cardiovascular research field to explore novel concepts with promising prognostic and therapeutic potential. This review attempts to introduce the newly emerging field of epitranscriptome (or else known as RNA epigenetics) to cardiovascular researchers and clinicians summarizing its applications on health and disease. The traditionally perceived, intermediate carrier of genetic information or as contemporary revised as, occasionally, even the final product of gene expression, RNA, is dynamically subjected to >140 different kinds of chemical modifications determining its fate, which may profoundly impact the cellular responses and thus both health and disease course. Which are the most prevalent types of these RNA modifications, how are they catalyzed, how are they regulated, which role may they play in health and disease, and which are the implications for the cardiovascular medicine are few important questions that are discussed in the present review.
Author(s): Gatsiou A, Stellos K
Publication type: Article
Publication status: Published
Journal: Circulation: Genomic and Precision Medicine
Online publication date: 17/09/2018
Acceptance date: 02/04/2018
ISSN (print): 1942-325X
ISSN (electronic): 2574-8300
Publisher: Lippincott Williams & Wilkins
PubMed id: 30354331
Altmetrics provided by Altmetric